News

Newsletter

Decree regulates the free provision of cannabidiol-based medications by the Unified Health System of São Paulo

On December 26, 2023, Decree No. 68,233/2023 was published in the Official Gazette of São Paulo, regulating the free provision of cannabidiol (CBD)-based medications and related compounds of medicinal cannabis by the Unified Health System (SUS) of São Paulo.

This Decree establishes guidelines in accordance with Law No. 17,618, dated January 31, 2023, addressing the state policy for the distribution of formulated products containing plant-derived derivatives of cannabidiol — associated with other cannabinoid substances, including tetrahydrocannabinol — in state-owned and privately affiliated public health units under the Unified Health System – SUS.

In this context, to access cannabidiol-based medication, patients or their legal representative must submit a request. Subsequently, the Department of Health will conduct an evaluation, adhering to clinical protocols and state technical standards.

Nevertheless, as per Article 3 of the mentioned Decree, the provision of this medicinal product will only occur if the product is registered with the National Health Surveillance Agency (ANVISA). The Decree also references ANVISA’s RDC 327/2019, which must be complied with, as it outlines procedures for granting Health Authorization, manufacturing, and importing, as well as setting requirements for the commercialization, prescription, dispensing, monitoring, and inspection of Cannabis products for medicinal purposes.

In addition to regulating the provision of cannabidiol-based medications, the Decree also encompasses the establishment of a monitoring committee to oversee patients using these medications, aiming to assess information and propose the use of new medications to the National Committee for the Incorporation of Technologies in SUS (Conitec).

Decree No. 68,233/2023 came into effect upon its publication in the Official Gazette. Consequently, following the authorization of the State Health Department, the medication will be available in specialized pharmacies and can be obtained upon presentation of the required documents.

For further content related to the regulation of medicinal cannabis, do not hesitate to contact us via email at: regulatorio@kasznarleonardos.com.

Back

Last related news

February 1, 2024

Betting Market and the Creation of the Secretariat of Prizes and Bets by Decree 11.907/2024

On Wednesday, January 31, 2024, Decree No. 11.907/2024 was published in the Official Gazette, creating the Secretariat of Prizes and Bets (SPA) Betting Market and the Creation of the Secretariat of Prizes and Bets by Decree 11.907/2024

Ler notícia

January 19, 2024

New Law expands Ancine’s role in the fight against piracy of audiovisual content

The enactment of Law No. 14,815 on January 16 of this year marks a significant milestone in the fight against piracy of New Law expands Ancine’s role in the fight against piracy of audiovisual content

Ler notícia

January 9, 2024

Decree regulates the free provision of cannabidiol-based medications by the Unified Health System of São Paulo

On December 26, 2023, Decree No. 68,233/2023 was published in the Official Gazette of São Paulo, regulating the free provision of cannabidiol Decree regulates the free provision of cannabidiol-based medications by the Unified Health System of São Paulo

Ler notícia
plugins premium WordPress